GWDN Stocks Mixed in July; Affy Soars, Myriad Sags | GenomeWeb

NEW YORK (GenomeWeb News) – Despite the Dow Jones Industrial Average returning its best month — rising 8.6 percent for the month of July — in 20 years, the stocks that comprise the GenomeWeb Daily News Index produced mixed results for the month.

Overall, the GWDN Index gained 1 percent for July, but several firms returned significant gains and losses for the month, partly due to investors' reactions to second-quarter financial results. Two of the biggest gainers, though — Sequenom and Nanosphere — have yet to report.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.